Position in WVE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$495,505
-$122,811 QoQ
Shares Held
85,285
0.0% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#101
of 237 holders
Holding Since
Mar 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Derivatives in WVE
reported options exposure · as of Mar 31, 2021CallValue
$1,402,500
CallShares
250,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. WVE ranks #80 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in WVE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $495,505 | 85,285 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $618,316 | 85,285 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,449,845 | 85,285 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $702,390 | 95,955 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,047,390 | 161,137 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $4,462,973 | 544,265 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,869,689 | 575,088 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,640,842 | 590,088 | Shares | Sole | 2024-05-17 | |
| 2022-06-30 | $318,626 | 98,039 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,096,078 | 1,048,039 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,119,530 | 993,481 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,868,056 | 993,481 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $1,402,500 | 250,000 | Call | Sole | 2021-08-18 | |
| No filing history on record for this holder in this stock. | ||||||